A Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)
Condition(s):Amyotrophic Lateral SclerosisLast Updated:July 21, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Amyotrophic Lateral SclerosisLast Updated:July 21, 2020Completed
Condition(s):Alcohol Use DisordersLast Updated:February 23, 2016Completed
Condition(s):Amyotrophic Lateral SclerosisLast Updated:March 15, 2024Recruiting
Condition(s):Alcohol Use DisorderLast Updated:July 13, 2023Completed
Condition(s):Pneumonia, ViralLast Updated:May 30, 2023Active, not recruiting
Condition(s):Multiple Sclerosis, Primary Progressive; Multiple Sclerosis, Secondary ProgressiveLast Updated:July 28, 2020Completed
Condition(s):Migraine HeadacheLast Updated:December 29, 2015Completed
Condition(s):Glioblastoma; Recurrent Glioblastoma; GBM; Newly Diagnosed GlioblastomaLast Updated:March 15, 2024Active, not recruiting
Condition(s):Alcohol Use Disorder (AUD); AlcoholismLast Updated:August 15, 2023Recruiting
Condition(s):Methamphetamine-dependenceLast Updated:January 8, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.